Taysha Gene Therapies, Inc.
2020 Q4 - 2025 Q4 (14 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/12/2026 | 371 | 0.0% | 67,500 | 12/31/2025 |
| 2025 Q3 | 11/3/2025 | 221 | 0.0% | 67,600 | 9/30/2025 |
| 2025 Q2 | 10/8/2025 | 49 | 0.0% | 21,100 | 6/30/2025 |
| 2025 Q1 | 10/8/2025 | 29 | 0.0% | 21,100 | 3/31/2025 |
| 2024 Q4 | 10/8/2025 | 37 | 0.0% | 21,100 | 12/31/2024 |
| 2024 Q3 | 10/8/2025 | 42 | 0.0% | 21,100 | 9/30/2024 |
| 2024 Q2 | 10/8/2025 | 145 | 0.0% | 64,800 | 6/30/2024 |
| 2022 Q2 | 8/4/2022 | 1 | 0.0% | 191 | 6/30/2022 |
| 2022 Q1 | 7/1/2022 | 93 | 0.0% | 14,291 | 3/31/2022 |
| 2021 Q4 | 2/2/2022 | 166 | 0.0% | 14,287 | 12/31/2021 |
| 2021 Q3 | 11/2/2021 | 267 | 0.0% | 14,327 | 9/30/2021 |
| 2021 Q2 | 8/2/2021 | 406 | 0.0% | 19,174 | 6/30/2021 |
| 2021 Q1 | 5/11/2021 | 179 | 0.0% | 8,800 | 3/31/2021 |
| 2020 Q4 | 2/8/2021 | 130 | 0.0% | 4,900 | 12/31/2020 |